BNTX
Price
$113.92
Change
+$2.14 (+1.91%)
Updated
Jul 10 closing price
Capitalization
26.87B
24 days until earnings call
NVAX
Price
$7.10
Change
+$0.06 (+0.85%)
Updated
Jul 10 closing price
Capitalization
1.14B
26 days until earnings call
Interact to see
Advertisement

BNTX vs NVAX

Header iconBNTX vs NVAX Comparison
Open Charts BNTX vs NVAXBanner chart's image
BioNTech SE American Depositary Share
Price$113.92
Change+$2.14 (+1.91%)
Volume$667.96K
Capitalization26.87B
Novavax
Price$7.10
Change+$0.06 (+0.85%)
Volume$2.97M
Capitalization1.14B
BNTX vs NVAX Comparison Chart in %
Loading...
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNTX vs. NVAX commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTX is a StrongBuy and NVAX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (BNTX: $113.92 vs. NVAX: $7.10)
Brand notoriety: BNTX: Not notable vs. NVAX: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNTX: 70% vs. NVAX: 31%
Market capitalization -- BNTX: $26.87B vs. NVAX: $1.14B
BNTX [@Biotechnology] is valued at $26.87B. NVAX’s [@Biotechnology] market capitalization is $1.14B. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNTX’s FA Score shows that 2 FA rating(s) are green whileNVAX’s FA Score has 1 green FA rating(s).

  • BNTX’s FA Score: 2 green, 3 red.
  • NVAX’s FA Score: 1 green, 4 red.
According to our system of comparison, BNTX is a better buy in the long-term than NVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNTX’s TA Score shows that 3 TA indicator(s) are bullish while NVAX’s TA Score has 4 bullish TA indicator(s).

  • BNTX’s TA Score: 3 bullish, 4 bearish.
  • NVAX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both BNTX and NVAX are a bad buy in the short-term.

Price Growth

BNTX (@Biotechnology) experienced а +3.56% price change this week, while NVAX (@Biotechnology) price change was +4.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

BNTX is expected to report earnings on Nov 03, 2025.

NVAX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNTX($26.9B) has a higher market cap than NVAX($1.14B). BNTX has higher P/E ratio than NVAX: BNTX (161.76) vs NVAX (2.58). BNTX YTD gains are higher at: -0.026 vs. NVAX (-11.692). NVAX has higher annual earnings (EBITDA): 555M vs. BNTX (-447M). BNTX has more cash in the bank: 14.1B vs. NVAX (731M). NVAX has less debt than BNTX: NVAX (229M) vs BNTX (293M). BNTX has higher revenues than NVAX: BNTX (2.75B) vs NVAX (1.22B).
BNTXNVAXBNTX / NVAX
Capitalization26.9B1.14B2,360%
EBITDA-447M555M-81%
Gain YTD-0.026-11.6920%
P/E Ratio161.762.586,265%
Revenue2.75B1.22B226%
Total Cash14.1B731M1,929%
Total Debt293M229M128%
FUNDAMENTALS RATINGS
NVAX: Fundamental Ratings
NVAX
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
32
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNTXNVAX
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 23 days ago
81%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TNA37.670.55
+1.48%
Direxion Daily Small Cap Bull 3X ETF
TPLE27.180.17
+0.64%
Timothy Plan US Large/Mid Cp Cr Enh ETF
JHCR25.130.09
+0.38%
JHancock Core Bond ETF
BAPR45.430.04
+0.09%
Innovator U.S. Equity Buffer ETF™ - Apr
BNO30.20-0.52
-1.69%
United States Brent Oil

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with SMMT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
+1.91%
SMMT - BNTX
51%
Loosely correlated
+4.61%
TIL - BNTX
50%
Loosely correlated
+4.41%
MRNA - BNTX
48%
Loosely correlated
+4.54%
ARCT - BNTX
47%
Loosely correlated
-2.10%
KYMR - BNTX
43%
Loosely correlated
+0.07%
More